Document is current
Any future updates will be listed below
-
Authors
Towers, Christina G.
Guarnieri, Anna L.
Micalizzi, Doug S.
Harrell, J. Chuck
Gillen, Austin E. https://orcid.org/0000-0003-2928-6308
Kim, Jihye
Wang, Chu-An
Oliphant, Michael U.J.
Drasin, David J.
Guney, Michelle A.
Kabos, Peter
Sartorius, Carol A.
Tan, Aik-Choon
Perou, Charles M.
Espinosa, Joaquin M.
Ford, Heide L.
- License Information
-
More Information
Article History
Received: 7 April 2015
Accepted: 2 November 2015
First Online: 21 December 2015
Competing interests
: C.M.P. is an equity stock holder, and Board of Director Member, of BioClassifier LLC and GeneCentric Diagnostics. C.M.P. is also listed as an inventor on patent applications on the Breast PAM50 assay. H.L.F. is affiliated with SixOne Solutions, previously awarded an STTR grant (R41CA180347) for developing inhibitors against the Eya phosphatase, part of the Six1 transcriptional complex. The remaining authors declare no competing financial interests.
